SCHEMBL2485798

SCHEMBL2485798

[CH]=CCCC(=C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28235760 0.81
SCHEMBL42883 0.73
SCHEMBL10399018 0.73
SCHEMBL6421035 0.72
SCHEMBL347376 0.71
SCHEMBL8053020 0.71
SCHEMBL2162628 0.71
SCHEMBL18739416 0.71
SCHEMBL5826957 0.71
SCHEMBL347377 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109924-A1 IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS VIFOR (INTERNATIONAL) LTD. (CH) 2024-04-04 US disclosed
EP-4284809-A1 IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS Sanifit Therapeutics S.A. (ES) 2023-12-06 EP disclosed
CN-115417791-B Oxime ether 1, 3-cyclohexanedione compound and synthetic method and application thereof 郑州手性药物研究院有限公司 2023-10-27 CN disclosed
US-20230340003-A1 PROCESSES FOR THE PREPARATION OF SOLUBLE SALTS OF INOSITOL PHOSPHATES VIFOR (INTERNATIONAL) LTD. (CH) 2023-10-26 US disclosed
EP-4263561-A1 PROCESSES FOR THE PREPARATION OF SOLUBLE SALTS OF INOSITOL PHOSPHATES Sanifit Therapeutics S.A. (ES) 2023-10-25 EP disclosed
CN-116709916-A [ (1-phenyl-5-heteroaryl-1H-pyrazol-3-yl) oxy ] acetic acid derivatives as safeners for protecting useful plants and crop plants 拜耳公司 2023-09-05 CN disclosed
US-20230248749-A1 INOSITOL PHOSPHATE COMPOUNDS FOR USE IN INCREASING TISSULAR PERFUSION SANIFIT THERAPEUTICS, S.A. (ES) 2023-08-10 US disclosed
EP-4058030-A1 INOSITOL PHOSPHATE COMPOUNDS FOR USE IN TREATING, INHIBITING THE PROGRESSION, OR PREVENTING CARDIOVASCULAR CALCIFICATION Sanifit Therapeutics S.A. (ES) 2022-09-21 EP disclosed
WO-2022129148-A1 PROCESSES FOR THE PREPARATION OF SOLUBLE SALTS OF INOSITOL PHOSPHATES SANIFIT THERAPEUTICS, S.A. (ES) 2022-06-23 WO disclosed
EP-4015494-A1 PROCESSES FOR THE PREPARATION OF SOLUBLE SALTS OF INOSITOL PHOSPHATES Sanifit Therapeutics S.A. (ES) 2022-06-22 EP disclosed
EP-1943275-A1 INSULINOTROPIC COMPOUNDS AND USES THEREOF Activotec SPP Limited (GB) 2008-07-16 EP disclosed
EP-1922321-A1 PYRAZOLOÝ1,5-A¨PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Eirx Therapeutics Ltd (IE) 2008-05-21 EP disclosed
WO-2007051987-A1 INSULINOTROPIC COMPOUNDS AND USES THEREOF ACTIVOTEC SPP LIMITED (GB) 2007-05-10 WO disclosed
WO-2007017678-A1 PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM EIRX THERAPEUTICS LIMITED (IE) 2007-02-15 WO disclosed
EP-0970044-B1 CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF BASF AG (DE) 2003-05-07 EP disclosed
US-4755598-A 1'-(substituted)ethyl-7β-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylate derivatives having antibacterial utility TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-07-05 US disclosed
EP-0128028-A2 Cephalosporin derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1984-12-12 EP disclosed
EP-0081054-A2 Azabicyclo alkyl derivatives BEECHAM GROUP PLC (GB) 1983-06-15 EP disclosed
US-4273778-A TREATMENT OF GASTROINTESTINAL DISORDERS, NERVOUS SYSTEM DISORDERS, AND PSYCHOLOGICAL DISORDERS BEECHAM GROUP, LIMITED (GB) 1981-06-16 US disclosed
EP-0013138-A1 Azabicycloalkyl derivatives, a process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1980-07-09 EP disclosed